<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35749015</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical reviews in allergy &amp; immunology</Title><ISOAbbreviation>Clin Rev Allergy Immunol</ISOAbbreviation></Journal><ArticleTitle>A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sj&#xf6;gren's Syndrome.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>411</EndPage><MedlinePgn>392-411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12016-022-08951-z</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sj&#xf6;gren's syndrome are four major autoimmune rheumatic diseases characterized by the presence of autoantibodies, caused by a dysregulation of the immune system that leads to a wide variety of clinical manifestations. These conditions present complex etiologies strongly influenced by multiple environmental and genetic factors. The human leukocyte antigen (HLA) region was the first locus identified to be associated and still represents the strongest susceptibility factor for each of these conditions, particularly the HLA class II genes, including DQA1, DQB1, and DRB1, but class I genes have also been associated. Over the last two decades, the genetic component of these disorders has been extensively investigated and hundreds of non-HLA risk genetic variants have been uncovered. Furthermore, it is widely accepted that autoimmune rheumatic diseases share molecular disease pathways, such as the interferon (IFN) type I pathways, which are reflected in a common genetic background. Some examples of well-known pleiotropic loci for autoimmune rheumatic diseases are the HLA region, DNASEL13, TNIP1, and IRF5, among others. The identification of the causal molecular mechanisms behind the genetic associations is still a challenge. However, recent advances have been achieved through mouse models and functional studies of the loci. Here, we provide an updated overview of the genetic architecture underlying these four autoimmune rheumatic diseases, with a special focus on the HLA region.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ort&#xed;z-Fern&#xe1;ndez</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Parasitology and Biomedicine L&#xf3;pez-Neyra, CSIC, Parque Tecnol&#xf3;gico de La Salud, 18016, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Parasitology and Biomedicine L&#xf3;pez-Neyra, CSIC, Parque Tecnol&#xf3;gico de La Salud, 18016, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n-Riquelme</LastName><ForeName>Marta E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-7632-4154</Identifier><AffiliationInfo><Affiliation>GENYO. Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av de la Ilustraci&#xf3;n 114, Parque Tecnol&#xf3;gico de La Salud, 18016, Granada, Spain. marta.alarcon@genyo.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Environmental Medicine, Karolinska Institutet, 171 77, Solna, Sweden. marta.alarcon@genyo.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Rev Allergy Immunol</MedlineTA><NlmUniqueID>9504368</NlmUniqueID><ISSNLinking>1080-0549</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000949">Histocompatibility Antigens Class II</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498178">Irf5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050835">Interferon Regulatory Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000949" MajorTopicYN="N">Histocompatibility Antigens Class II</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050835" MajorTopicYN="N">Interferon Regulatory Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Common variation</Keyword><Keyword MajorTopicYN="N">Genome-wide association study</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Systemic sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35749015</ArticleId><ArticleId IdType="doi">10.1007/s12016-022-08951-z</ArticleId><ArticleId IdType="pii">10.1007/s12016-022-08951-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cho JH, Feldman M (2015) Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med 21:730&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">26121193</ArticleId><ArticleId IdType="pmc">5716342</ArticleId><ArticleId IdType="doi">10.1038/nm.3897</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper GS, Bynum MLK, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197&#x2013;207</Citation><ArticleIdList><ArticleId IdType="pubmed">19819109</ArticleId><ArticleId IdType="pmc">2783422</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2009.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754&#x2013;765</Citation><ArticleIdList><ArticleId IdType="pubmed">22387972</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2012.02.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP et al (2015). Systemic sclerosis Nature Reviews Disease Primers. https://doi.org/10.1038/nrdp.2015.2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.2</ArticleId><ArticleId IdType="pubmed">27189141</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685&#x2013;1699</Citation><ArticleIdList><ArticleId IdType="pubmed">28413064</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(17)30933-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A (2014) A potential link between environmental triggers and autoimmunity. Autoimmune Dis 2014:437231</Citation><ArticleIdList><ArticleId IdType="pubmed">24688790</ArticleId><ArticleId IdType="pmc">3945069</ArticleId></ArticleIdList></Reference><Reference><Citation>Munroe ME, Anderson JR, Gross TF, Stunz LL, Bishop GA, James JA (2020) Epstein-Barr functional mimicry: pathogenicity of oncogenic latent membrane protein-1 in systemic lupus erythematosus and autoimmunity. Front Immunol 11:606936</Citation><ArticleIdList><ArticleId IdType="pubmed">33613527</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2020.606936</ArticleId></ArticleIdList></Reference><Reference><Citation>Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P et al (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35:311&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">1536669</ArticleId><ArticleId IdType="doi">10.1002/art.1780350310</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali-Bostwick C, Medsger TA Jr, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48:1956&#x2013;1963</Citation><ArticleIdList><ArticleId IdType="pubmed">12847690</ArticleId><ArticleId IdType="doi">10.1002/art.11173</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">10643697</ArticleId><ArticleId IdType="doi">10.1002/1529-0131(200001)43:1&lt;30::AID-ANR5&gt;3.0.CO;2-B</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Segovia D, Alarc&#xf3;n-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR et al (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 52:1138&#x2013;1147</Citation><ArticleIdList><ArticleId IdType="pubmed">15818688</ArticleId><ArticleId IdType="doi">10.1002/art.20999</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard-Miceli C, Criswell LA (2012) Emerging patterns of genetic overlap across autoimmune disorders. Genome Med 4:6</Citation><ArticleIdList><ArticleId IdType="pubmed">22284131</ArticleId><ArticleId IdType="pmc">3334554</ArticleId><ArticleId IdType="doi">10.1186/gm305</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumet FC, Coukell A, Bodmer JG, Bodmer WF, McDevitt HO (1971) Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med 285:193&#x2013;196</Citation></Reference><Reference><Citation>McMichael AJ, Sasazuki T, McDevitt HO, Payne RO (1977) Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum 20:1037&#x2013;1042</Citation><ArticleIdList><ArticleId IdType="pubmed">869952</ArticleId><ArticleId IdType="doi">10.1002/art.1780200501</ArticleId></ArticleIdList></Reference><Reference><Citation>Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869&#x2013;871</Citation><ArticleIdList><ArticleId IdType="pubmed">147420</ArticleId><ArticleId IdType="doi">10.1056/NEJM197804202981602</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RJ, Bridges SL Jr, Ahmed S (2019) HLA-C: an accomplice in rheumatic diseases. ACR Open Rheumatol 1:571&#x2013;579</Citation><ArticleIdList><ArticleId IdType="pubmed">31777841</ArticleId><ArticleId IdType="pmc">6858028</ArticleId><ArticleId IdType="doi">10.1002/acr2.11065</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Taylor KE, Fernando MMA, Nititham J, Alarc&#xf3;n-Riquelme ME, Barcellos LF et al (2012) Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet 91:778&#x2013;793</Citation><ArticleIdList><ArticleId IdType="pubmed">23084292</ArticleId><ArticleId IdType="pmc">3487133</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2012.08.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y et al (2013) The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand. Int J Immunogenet 40:126&#x2013;130</Citation><ArticleIdList><ArticleId IdType="pubmed">22862923</ArticleId><ArticleId IdType="doi">10.1111/j.1744-313X.2012.01145.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Riquelme ME, Ziegler JT, Molineros J, Howard TD, Moreno-Estrada A, S&#xe1;nchez-Rodr&#xed;guez E et al (2016) Genome-wide association study in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture. Arthritis Rheumatol 68:932&#x2013;943</Citation><ArticleIdList><ArticleId IdType="pubmed">26606652</ArticleId><ArticleId IdType="pmc">4829354</ArticleId><ArticleId IdType="doi">10.1002/art.39504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Morris DL, Noble JA, Dilthey AT, Tombleson P, Kaufman KM et al (2018) Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet 27:3813&#x2013;3824</Citation><ArticleIdList><ArticleId IdType="pubmed">30085094</ArticleId><ArticleId IdType="pmc">6196648</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddy280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang S-Y, Lee H-S, Okada Y, Han B, Saw W-Y et al (2014) The HLA-DR&#x3b2;1 amino acid positions 11&#x2013;13-26 explain the majority of SLE-MHC associations. Nat Commun 5:5902</Citation><ArticleIdList><ArticleId IdType="pubmed">25533202</ArticleId><ArticleId IdType="doi">10.1038/ncomms6902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Molineros JE, Looger LL, Zhou X-J, Kim K, Okada Y et al (2016) High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet 48:323&#x2013;330</Citation><ArticleIdList><ArticleId IdType="pubmed">26808113</ArticleId><ArticleId IdType="pmc">4767573</ArticleId><ArticleId IdType="doi">10.1038/ng.3496</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M (1989) Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sj&#xf6;gren&#x2019;s syndrome. Arthritis Rheum 32:413&#x2013;419</Citation><ArticleIdList><ArticleId IdType="pubmed">2706027</ArticleId><ArticleId IdType="doi">10.1002/anr.1780320410</ArticleId></ArticleIdList></Reference><Reference><Citation>Molineros JE, Looger LL, Kim K, Okada Y, Terao C, Sun C et al (2019) Amino acid signatures of HLA class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians. PLoS Genet 15:e1008092</Citation><ArticleIdList><ArticleId IdType="pubmed">31022184</ArticleId><ArticleId IdType="pmc">6504188</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1008092</ArticleId></ArticleIdList></Reference><Reference><Citation>Barturen G, Babaei S, Catal&#xe0;-Moll F, Mart&#xed;nez-Bueno M, Makowska Z, Martorell-Marug&#xe1;n J et al (2021) Integrative analysis reveals a molecular stratification of systemic autoimmune diseases. Arthritis Rheumatol 73:1073&#x2013;1085</Citation><ArticleIdList><ArticleId IdType="pubmed">33497037</ArticleId><ArticleId IdType="doi">10.1002/art.41610</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj P, Rai E, Song R, Khan S, Wakeland BE, Viswanathan K et al (2016) Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife 5.&#xa0; https://doi.org/10.7554/eLife.12089</Citation></Reference><Reference><Citation>Miller S, Tsou P-S, Coit P, Gensterblum-Miller E, Renauer P, Rohraff DM et al (2019) Hypomethylation of STAT1 and HLA-DRB1 is associated with type-I interferon-dependent HLA-DRB1 expression in lupus CD8+ T cells. Ann Rheum Dis 78:519&#x2013;528</Citation><ArticleIdList><ArticleId IdType="pubmed">30674474</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2018-214323</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Herrera M, Kerick M, Lop&#xe9;z-Isac E, Assassi S, Beretta L, Sime&#xf3;n-Aznar CP et al (2021) Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2021-219884</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-219884</ArticleId><ArticleId IdType="pubmed">34096881</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Serna D, L&#xf3;pez-Isac E, Yilmaz N, Gharibdoost F, Jamshidi A, Kavosi H et al (2019) Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study. Rheumatology 58:289&#x2013;298</Citation><ArticleIdList><ArticleId IdType="pubmed">30247649</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/key281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA et al (2020) HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A 117:552&#x2013;562</Citation><ArticleIdList><ArticleId IdType="pubmed">31871193</ArticleId><ArticleId IdType="doi">10.1073/pnas.1906593116</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK et al (2010) Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 69:822&#x2013;827</Citation><ArticleIdList><ArticleId IdType="pubmed">19596691</ArticleId><ArticleId IdType="doi">10.1136/ard.2009.111906</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta L, Rueda B, Marchini M, Santaniello A, Sime&#xf3;n CP, Fonollosa V et al (2012) Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology 51:52&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">22087014</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/ker335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Reyna TS, Mercado-Vel&#xe1;zquez P, Yu N, Alosco S, Ohashi M, Lebedeva T et al (2015) HLA class I and II blocks are associated to susceptibility, clinical subtypes and autoantibodies in Mexican systemic sclerosis (SSc) patients. PLoS ONE 10:e0126727</Citation><ArticleIdList><ArticleId IdType="pubmed">25993664</ArticleId><ArticleId IdType="pmc">4439150</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0126727</ArticleId></ArticleIdList></Reference><Reference><Citation>Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M et al (2017) Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis 76:1150&#x2013;1158</Citation><ArticleIdList><ArticleId IdType="pubmed">28314753</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2016-210645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H et al (2011) Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol 38:1622&#x2013;1630</Citation><ArticleIdList><ArticleId IdType="pubmed">21572159</ArticleId><ArticleId IdType="pmc">3149738</ArticleId><ArticleId IdType="doi">10.3899/jrheum.110071</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV et al (2014) Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 94:47&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">24387989</ArticleId><ArticleId IdType="pmc">3882906</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2013.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorlova O, Martin J-E, Rueda B, Koeleman BPC, Ying J, Teruel M et al (2011) Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 7:e1002178</Citation><ArticleIdList><ArticleId IdType="pubmed">21779181</ArticleId><ArticleId IdType="pmc">3136437</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1002178</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J et al (2019) GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat Commun 10:4955</Citation><ArticleIdList><ArticleId IdType="pubmed">31672989</ArticleId><ArticleId IdType="pmc">6823490</ArticleId><ArticleId IdType="doi">10.1038/s41467-019-12760-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205&#x2013;1213</Citation></Reference><Reference><Citation>Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee H-S, Jia X et al (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44:291&#x2013;296</Citation><ArticleIdList><ArticleId IdType="pubmed">22286218</ArticleId><ArticleId IdType="pmc">3288335</ArticleId><ArticleId IdType="doi">10.1038/ng.1076</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B, Diogo D, Eyre S, Kallberg H, Zhernakova A, Bowes J et al (2014) Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet 94:522&#x2013;532</Citation><ArticleIdList><ArticleId IdType="pubmed">24656864</ArticleId><ArticleId IdType="pmc">3980428</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2014.02.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Suzuki A, Ikari K, Terao C, Kochi Y, Ohmura K et al (2016) Contribution of a non-classical HLA gene, HLA-DOA, to the risk of rheumatoid arthritis. Am J Hum Genet 99:366&#x2013;374</Citation><ArticleIdList><ArticleId IdType="pubmed">27486778</ArticleId><ArticleId IdType="pmc">4974094</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2016.06.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Viatte S, Plant D, Han B, Fu B, Yarwood A, Thomson W et al (2015) Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA 313:1645&#x2013;1656</Citation><ArticleIdList><ArticleId IdType="pubmed">25919528</ArticleId><ArticleId IdType="pmc">4928097</ArticleId><ArticleId IdType="doi">10.1001/jama.2015.3435</ArticleId></ArticleIdList></Reference><Reference><Citation>Terao C, Brynedal B, Chen Z, Jiang X, Westerlind H, Hansson M et al (2019) Distinct HLA Associations with rheumatoid arthritis subsets defined by serological subphenotype. Am J Hum Genet 105:880</Citation><ArticleIdList><ArticleId IdType="pubmed">31585111</ArticleId><ArticleId IdType="pmc">6817550</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2019.09.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE (2020) IPD-IMGT/HLA database. Nucleic Acids Res 48:D948&#x2013;D955</Citation><ArticleIdList><ArticleId IdType="pubmed">31667505</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LK, Too CL, Diaz-Gallo LM, Wahinuddin S, Lau IS, Heselynn H et al (2021) The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study. Arthritis Res Ther 23:46</Citation><ArticleIdList><ArticleId IdType="pubmed">33514426</ArticleId><ArticleId IdType="pmc">7847037</ArticleId><ArticleId IdType="doi">10.1186/s13075-021-02431-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes A, Brown MA (2011) Promise and pitfalls of the Immunochip. Arthritis Res Ther 13:101</Citation><ArticleIdList><ArticleId IdType="pubmed">21345260</ArticleId><ArticleId IdType="pmc">3157635</ArticleId><ArticleId IdType="doi">10.1186/ar3204</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C et al (2019) The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47:D1005&#x2013;D1012</Citation><ArticleIdList><ArticleId IdType="pubmed">30445434</ArticleId><ArticleId IdType="doi">10.1093/nar/gky1120</ArticleId></ArticleIdList></Reference><Reference><Citation>Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22:431&#x2013;456</Citation><ArticleIdList><ArticleId IdType="pubmed">15032584</ArticleId><ArticleId IdType="doi">10.1146/annurev.immunol.22.012703.104549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JY, Wu YL, Mok MY, Wu Y-JJ, Lintner KE, Wang C-M et al (2016) Effects of complement C4 gene copy number variations, size dichotomy, and C4A deficiency on genetic risk and clinical presentation of systemic lupus erythematosus in East Asian populations. Arthritis Rheumatol 68:1442&#x2013;1453</Citation></Reference><Reference><Citation>J&#xfc;ptner M, Flachsbart F, Caliebe A, Lieb W, Schreiber S, Zeuner R et al (2018) Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus. Lupus 27:600&#x2013;609</Citation><ArticleIdList><ArticleId IdType="pubmed">29050534</ArticleId><ArticleId IdType="doi">10.1177/0961203317735187</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskenmies S, Widen E, Kere J, Julkunen H (2001) Familial systemic lupus erythematosus in Finland. J Rheumatol 28:758&#x2013;760</Citation><ArticleIdList><ArticleId IdType="pubmed">11327246</ArticleId></ArticleIdList></Reference><Reference><Citation>Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J et al (2002) Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 46:2132&#x2013;2140</Citation><ArticleIdList><ArticleId IdType="pubmed">12209518</ArticleId><ArticleId IdType="doi">10.1002/art.10438</ArticleId></ArticleIdList></Reference><Reference><Citation>Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS et al (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 172:7186&#x2013;7191</Citation></Reference><Reference><Citation>Sigurdsson S, Nordmark G, G&#xf6;ring HHH, Lindroos K, Wiman A-C, Sturfelt G et al (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76:528&#x2013;537</Citation><ArticleIdList><ArticleId IdType="pubmed">15657875</ArticleId><ArticleId IdType="pmc">1196404</ArticleId><ArticleId IdType="doi">10.1086/428480</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Kozyrev SV, Baechler EC, Reddy MVPL, Plenge RM, Bauer JW et al (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38:550&#x2013;555</Citation><ArticleIdList><ArticleId IdType="pubmed">16642019</ArticleId><ArticleId IdType="doi">10.1038/ng1782</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LRL, Baechler EC et al (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104:6758&#x2013;6763</Citation><ArticleIdList><ArticleId IdType="pubmed">17412832</ArticleId><ArticleId IdType="pmc">1847749</ArticleId><ArticleId IdType="doi">10.1073/pnas.0701266104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozyrev SV, Lew&#xe9;n S, Reddy PMVL, Pons-Estel B, Argentine Collaborative Group, Witte T et al (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56:1234&#x2013;1241</Citation></Reference><Reference><Citation>Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM et al (2015) The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet 24:582&#x2013;596</Citation><ArticleIdList><ArticleId IdType="pubmed">25205108</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddu455</ArticleId></ArticleIdList></Reference><Reference><Citation>Begovich AB, Carlton VEH, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330&#x2013;337</Citation><ArticleIdList><ArticleId IdType="pubmed">15208781</ArticleId><ArticleId IdType="pmc">1216068</ArticleId><ArticleId IdType="doi">10.1086/422827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VEH et al (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504&#x2013;507</Citation><ArticleIdList><ArticleId IdType="pubmed">15273934</ArticleId><ArticleId IdType="pmc">1182029</ArticleId><ArticleId IdType="doi">10.1086/423790</ArticleId></ArticleIdList></Reference><Reference><Citation>Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977&#x2013;986</Citation><ArticleIdList><ArticleId IdType="pubmed">17804842</ArticleId><ArticleId IdType="pmc">2630215</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa073003</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel ZH, Lu X, Miller D, Forney CR, Lee J, Lynch A et al (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet 27:2392&#x2013;2404</Citation><ArticleIdList><ArticleId IdType="pubmed">29912393</ArticleId><ArticleId IdType="pmc">6005081</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddy140</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagberg N, Joelsson M, Leonard D, Reid S, Eloranta M-L, Mo J et al (2018) The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-&#x3b3; production in T cells from patients with SLE. Ann Rheum Dis 77:1070&#x2013;1077</Citation><ArticleIdList><ArticleId IdType="pubmed">29475858</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2017-212794</ArticleId></ArticleIdList></Reference><Reference><Citation>International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarc&#xf3;n-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP et al (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204&#x2013;210</Citation></Reference><Reference><Citation>Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358:900&#x2013;909</Citation><ArticleIdList><ArticleId IdType="pubmed">18204098</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa0707865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozyrev SV, Abelson A-K, Wojcik J, Zaghlool A, Linga Reddy MVP, Sanchez E et al (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40:211&#x2013;216</Citation><ArticleIdList><ArticleId IdType="pubmed">18204447</ArticleId><ArticleId IdType="doi">10.1038/ng.79</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS et al (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40:152&#x2013;154</Citation><ArticleIdList><ArticleId IdType="pubmed">18204448</ArticleId><ArticleId IdType="doi">10.1038/ng.71</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD et al (2011) Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 63:3493&#x2013;3501</Citation><ArticleIdList><ArticleId IdType="pubmed">21792837</ArticleId><ArticleId IdType="pmc">3205224</ArticleId><ArticleId IdType="doi">10.1002/art.30563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47:1457&#x2013;1464</Citation><ArticleIdList><ArticleId IdType="pubmed">26502338</ArticleId><ArticleId IdType="pmc">4668589</ArticleId><ArticleId IdType="doi">10.1038/ng.3434</ArticleId></ArticleIdList></Reference><Reference><Citation>Georg I, D&#xed;az-Barreiro A, Morell M, Pey AL, Alarc&#xf3;n-Riquelme ME (2020) BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cell Mol Immunol 17:954&#x2013;965</Citation><ArticleIdList><ArticleId IdType="pubmed">31243359</ArticleId><ArticleId IdType="doi">10.1038/s41423-019-0254-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-Y, Kumar R, Iida R, Bagavant H, Alarc&#xf3;n-Riquelme ME (2016) BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation. PLoS ONE 11:e0156302</Citation><ArticleIdList><ArticleId IdType="pubmed">27228057</ArticleId><ArticleId IdType="pmc">4882053</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0156302</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez Hern&#xe1;ndez G, Morell M, Alarc&#xf3;n-Riquelme ME (2021) The role of BANK1 in B cell signaling and disease. Cells 10. https://doi.org/10.3390/cells10051184</Citation></Reference><Reference><Citation>Yang W, Zhao M, Hirankarn N, Lau CS, Mok CC, Chan TM et al (2009) ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 18:2063&#x2013;2070</Citation><ArticleIdList><ArticleId IdType="pubmed">19286673</ArticleId><ArticleId IdType="pmc">2678927</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddp118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim-Howard X, Maiti AK, Anaya J-M, Bruner GR, Brown E, Merrill JT et al (2010) ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis 69:1329&#x2013;1332</Citation><ArticleIdList><ArticleId IdType="pubmed">19939855</ArticleId><ArticleId IdType="doi">10.1136/ard.2009.120543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolin K, Sandling JK, Zickert A, J&#xf6;nsen A, Sj&#xf6;wall C, Svenungsson E et al (2013) Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS ONE 8:e84450</Citation><ArticleIdList><ArticleId IdType="pubmed">24386384</ArticleId><ArticleId IdType="pmc">3873995</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0084450</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C et al (2018) Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 50:699&#x2013;707</Citation><ArticleIdList><ArticleId IdType="pubmed">29662164</ArticleId><ArticleId IdType="pmc">6022759</ArticleId><ArticleId IdType="doi">10.1038/s41588-018-0102-3</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;fgren SE, Frosteg&#xe5;rd J, Truedsson L, Pons-Estel BA, D&#x2019;Alfonso S, Witte T et al (2012) Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun 13:268&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">22218224</ArticleId><ArticleId IdType="pmc">3640319</ArticleId><ArticleId IdType="doi">10.1038/gene.2011.84</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60:1065&#x2013;1075</Citation><ArticleIdList><ArticleId IdType="pubmed">19333922</ArticleId><ArticleId IdType="doi">10.1002/art.24436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou G, Harley ITW, Lu X, Zhou T, Xu N, Yao C et al (2021) SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat Commun 12:135</Citation><ArticleIdList><ArticleId IdType="pubmed">33420081</ArticleId><ArticleId IdType="pmc">7794586</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-20460-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris VM, Koelsch KA, Kurien BT, Harley ITW, Wren JD, Harley JB et al (2019) Characterization of cxorf21 provides molecular insight into female-bias immune response in SLE pathogenesis. Front Immunol 10:2160</Citation><ArticleIdList><ArticleId IdType="pubmed">31695690</ArticleId><ArticleId IdType="pmc">6816314</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.02160</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S et al (2018) TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol 3. https://doi.org/10.1126/sciimmunol.aap8855</Citation></Reference><Reference><Citation>Brown GJ, Ca&#xf1;ete PF, Wang H, Medhavy A, Bones J, Roco JA et al (2022) TLR7 gain-of-function genetic variation causes human lupus. Nature 605:349&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pubmed">35477763</ArticleId><ArticleId IdType="pmc">9095492</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC et al (2017) Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:16021</Citation><ArticleIdList><ArticleId IdType="pubmed">28714469</ArticleId><ArticleId IdType="pmc">5520018</ArticleId><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId></ArticleIdList></Reference><Reference><Citation>Radstake TRDJ, Gorlova O, Rueda B, Martin J-E, Alizadeh BZ, Palomino-Morales R et al (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42:426&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">20383147</ArticleId><ArticleId IdType="pmc">2861917</ArticleId><ArticleId IdType="doi">10.1038/ng.565</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore Y, Saad M, Dieud&#xe9; P, Avouac J, Distler JHW, Amouyel P et al (2011) Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 7:e1002091</Citation><ArticleIdList><ArticleId IdType="pubmed">21750679</ArticleId><ArticleId IdType="pmc">3131285</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1002091</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans LM, Tahmasbi R, Vrieze SI, Abecasis GR, Das S, Gazal S et al (2018) Comparison of methods that use whole genome data to estimate the heritability and genetic architecture of complex traits. Nat Genet 50:737&#x2013;745</Citation><ArticleIdList><ArticleId IdType="pubmed">29700474</ArticleId><ArticleId IdType="pmc">5934350</ArticleId><ArticleId IdType="doi">10.1038/s41588-018-0108-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossini-Castillo L, L&#xf3;pez-Isac E, Mayes MD, Mart&#xed;n J (2015) Genetics of systemic sclerosis. Semin Immunopathol 37:443&#x2013;451</Citation><ArticleIdList><ArticleId IdType="pubmed">26032405</ArticleId><ArticleId IdType="doi">10.1007/s00281-015-0499-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin J-E, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC et al (2012) Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up. Hum Mol Genet 21:2825&#x2013;2835</Citation><ArticleIdList><ArticleId IdType="pubmed">22407130</ArticleId><ArticleId IdType="pmc">3368627</ArticleId><ArticleId IdType="doi">10.1093/hmg/dds099</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieud&#xe9; P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M et al (2010) Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 69:1958&#x2013;1964</Citation><ArticleIdList><ArticleId IdType="pubmed">20511617</ArticleId><ArticleId IdType="doi">10.1136/ard.2009.127928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A et al (2014) An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Res Ther 16:438</Citation><ArticleIdList><ArticleId IdType="pubmed">25332064</ArticleId><ArticleId IdType="pmc">4230517</ArticleId><ArticleId IdType="doi">10.1186/s13075-014-0438-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossini-Castillo L, Villanueva-Martin G, Kerick M, Acosta-Herrera M, L&#xf3;pez-Isac E, Sime&#xf3;n CP et al (2021) Genomic risk score impact on susceptibility to systemic sclerosis. Ann Rheum Dis 80:118&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pubmed">33004331</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-218558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C, Dongqing Z, Yeqing S, Oaks MK, Lishan C, Jianzhong J et al (2005) Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 13:823&#x2013;828</Citation><ArticleIdList><ArticleId IdType="pubmed">15841095</ArticleId><ArticleId IdType="doi">10.1038/sj.ejhg.5201423</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395&#x2013;402</Citation><ArticleIdList><ArticleId IdType="pubmed">12833157</ArticleId><ArticleId IdType="doi">10.1038/ng1206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661&#x2013;678</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05911</ArticleId></ArticleIdList></Reference><Reference><Citation>Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PIW, Maller J et al (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39:1477&#x2013;1482</Citation><ArticleIdList><ArticleId IdType="pubmed">17982456</ArticleId><ArticleId IdType="pmc">2652744</ArticleId><ArticleId IdType="doi">10.1038/ng.2007.27</ArticleId></ArticleIdList></Reference><Reference><Citation>Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B et al (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis&#x2013;a genomewide study. N Engl J Med 357:1199&#x2013;1209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId><ArticleId IdType="pmc">2636867</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa073491</ArticleId></ArticleIdList></Reference><Reference><Citation>Juli&#xe0; A, Ballina J, Ca&#xf1;ete JD, Balsa A, Tornero-Molina J, Naranjo A et al (2008) Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum 58:2275&#x2013;2286</Citation><ArticleIdList><ArticleId IdType="pubmed">18668548</ArticleId><ArticleId IdType="doi">10.1002/art.23623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL et al (2009) REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 41:820&#x2013;823</Citation><ArticleIdList><ArticleId IdType="pubmed">19503088</ArticleId><ArticleId IdType="pmc">2705058</ArticleId><ArticleId IdType="doi">10.1038/ng.395</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P et al (2012) High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 44:1336&#x2013;1340</Citation><ArticleIdList><ArticleId IdType="pubmed">23143596</ArticleId><ArticleId IdType="pmc">3605761</ArticleId><ArticleId IdType="doi">10.1038/ng.2462</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A et al (2012) Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 44:511&#x2013;516</Citation><ArticleIdList><ArticleId IdType="pubmed">22446963</ArticleId><ArticleId IdType="doi">10.1038/ng.2231</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42:508&#x2013;514</Citation><ArticleIdList><ArticleId IdType="pubmed">20453842</ArticleId><ArticleId IdType="pmc">4243840</ArticleId><ArticleId IdType="doi">10.1038/ng.582</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pubmed">24390342</ArticleId><ArticleId IdType="doi">10.1038/nature12873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang S-Y, Lee H-S, Cho S-K, Choi C-B, Sung Y-K et al (2015) High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann Rheum Dis 74:e13</Citation><ArticleIdList><ArticleId IdType="pubmed">24532676</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2013-204749</ArticleId></ArticleIdList></Reference><Reference><Citation>Govind N, Choudhury A, Hodkinson B, Ickinger C, Frost J, Lee A et al (2014) Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans. Mol Med 20:341&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pubmed">25014791</ArticleId><ArticleId IdType="pmc">4153842</ArticleId><ArticleId IdType="doi">10.2119/molmed.2014.00097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha E, Bae S-C, Kim K (2021) Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann Rheum Dis 80:558&#x2013;565</Citation><ArticleIdList><ArticleId IdType="pubmed">33310728</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-219065</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena R, Plenge RM, Bjonnes AC, Dashti HS, Okada Y, Gad El Haq W et al (2017) A multinational Arab genome-wide association study identifies new genetic associations for rheumatoid arthritis. Arthritis Rheumatol 69: 976&#x2013;985</Citation></Reference><Reference><Citation>Laufer VA, Tiwari HK, Reynolds RJ, Danila MI, Wang J, Edberg JC et al (2019) Genetic influences on susceptibility to rheumatoid arthritis in African-Americans. Hum Mol Genet 28:858&#x2013;874</Citation><ArticleIdList><ArticleId IdType="pubmed">30423114</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddy395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y-C, Lim J, Bang S-Y, Ha E, Hwang MY, Yoon K et al (2020) Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis. Ann Rheum Dis 79:1438&#x2013;1445</Citation><ArticleIdList><ArticleId IdType="pubmed">32723749</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-217663</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng R-X, Di D-S, Ni J, Wu X-X, Zhang L-L, Wang X-F et al (2020) Identification of new susceptibility loci associated with rheumatoid arthritis. Ann Rheum Dis 79:1565&#x2013;1571</Citation><ArticleIdList><ArticleId IdType="pubmed">32868391</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-217351</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF et al (2012) Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 44:483&#x2013;489</Citation><ArticleIdList><ArticleId IdType="pubmed">22446960</ArticleId><ArticleId IdType="pmc">6560362</ArticleId><ArticleId IdType="doi">10.1038/ng.2232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R et al (2015) An atlas of genetic correlations across human diseases and traits. Nat Genet 47:1236&#x2013;1241</Citation><ArticleIdList><ArticleId IdType="pubmed">26414676</ArticleId><ArticleId IdType="pmc">4797329</ArticleId><ArticleId IdType="doi">10.1038/ng.3406</ArticleId></ArticleIdList></Reference><Reference><Citation>Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4(Suppl 3):S265&#x2013;S272</Citation><ArticleIdList><ArticleId IdType="pubmed">12110146</ArticleId><ArticleId IdType="pmc">3240153</ArticleId><ArticleId IdType="doi">10.1186/ar578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Byrne EM, Hultman CM, K&#xe4;hler A, Vinkhuyzen AAE, Ripke S et al (2015) New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol 44:1706&#x2013;1721</Citation><ArticleIdList><ArticleId IdType="pubmed">26286434</ArticleId><ArticleId IdType="pmc">4881824</ArticleId><ArticleId IdType="doi">10.1093/ije/dyv136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehlen MT, Olsen IC, Andreassen BK, Viken MK, Jiang X, Alfredsson L et al (2015) Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis. Ann Rheum Dis 74:762&#x2013;768</Citation><ArticleIdList><ArticleId IdType="pubmed">24336335</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2013-204173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarwood A, Han B, Raychaudhuri S, Bowes J, Lunt M, Pappas DA et al (2015) A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk. Ann Rheum Dis 74:170&#x2013;176</Citation><ArticleIdList><ArticleId IdType="pubmed">24092415</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2013-204133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks JA, Chen C-Y, Jiang X, Askling J, Hiraki LT, Malspeis S et al (2015) Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. Ann Rheum Dis 74:1522&#x2013;1529</Citation><ArticleIdList><ArticleId IdType="pubmed">24685909</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2013-205009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chibnik LB, Keenan BT, Cui J, Liao KP, Costenbader KH, Plenge RM et al (2011) Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset. PLoS ONE 6:e24380</Citation><ArticleIdList><ArticleId IdType="pubmed">21931699</ArticleId><ArticleId IdType="pmc">3171415</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0024380</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami S, Hoff M, Brown MA, Hveem K, Videm V (2020) Comparison of methods to construct a genetic risk score for prediction of rheumatoid arthritis in the population-based Nord-Tr&#xf8;ndelag Health Study. Norway Rheumatology 59:1743&#x2013;1751</Citation><ArticleIdList><ArticleId IdType="pubmed">31930319</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/kez638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Alfredsson L (2020) Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studies. Arthritis Res Ther 22:154</Citation><ArticleIdList><ArticleId IdType="pubmed">32571398</ArticleId><ArticleId IdType="pmc">7310443</ArticleId><ArticleId IdType="doi">10.1186/s13075-020-02253-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B, Shi H, Alfredsson L, Klareskog L, Padyukov L, Jiang X (2021) Obesity-related traits and the development of rheumatoid arthritis: evidence from genetic data. Arthritis Rheumatol 73:203&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pubmed">32964675</ArticleId><ArticleId IdType="doi">10.1002/art.41517</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, Zhang L, Wu DJH, Xie Z, Wen C, Mao Y (2020) Genetic predisposition to smoking is associated with risk of rheumatoid arthritis: a Mendelian randomization study. Arthritis Res Ther 22:44</Citation><ArticleIdList><ArticleId IdType="pubmed">32143697</ArticleId><ArticleId IdType="pmc">7060545</ArticleId><ArticleId IdType="doi">10.1186/s13075-020-2134-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM et al (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj&#xf6;gren&#x2019;s syndrome. Nat Genet 45:1284&#x2013;1292</Citation><ArticleIdList><ArticleId IdType="pubmed">24097067</ArticleId><ArticleId IdType="doi">10.1038/ng.2792</ArticleId></ArticleIdList></Reference><Reference><Citation>Song I-W, Chen H-C, Lin Y-F, Yang J-H, Chang C-C, Chou C-T et al (2016) Identification of susceptibility gene associated with female primary Sj&#xf6;gren&#x2019;s syndrome in Han Chinese by genome-wide association study. Hum Genet 135:1287&#x2013;1294</Citation><ArticleIdList><ArticleId IdType="pubmed">27503288</ArticleId><ArticleId IdType="doi">10.1007/s00439-016-1716-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KE, Wong Q, Levine DM, McHugh C, Laurie C, Doheny K et al (2017) Genome-wide association analysis reveals genetic heterogeneity of Sj&#xf6;gren&#x2019;s syndrome according to ancestry. Arthritis Rheumatol 69:1294&#x2013;1305</Citation><ArticleIdList><ArticleId IdType="pubmed">28076899</ArticleId><ArticleId IdType="pmc">5449251</ArticleId><ArticleId IdType="doi">10.1002/art.40040</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A et al (2017) Identification of a Sj&#xf6;gren&#x2019;s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet 13:e1006820</Citation><ArticleIdList><ArticleId IdType="pubmed">28640813</ArticleId><ArticleId IdType="pmc">5501660</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1006820</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P et al (2021) Genetic and clinical basis for two distinct subtypes of primary Sj&#xf6;gren&#x2019;s syndrome. Rheumatology 60:837&#x2013;848</Citation><ArticleIdList><ArticleId IdType="pubmed">32889544</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhernakova A, Withoff S, Wijmenga C (2013) Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 9:646&#x2013;659</Citation><ArticleIdList><ArticleId IdType="pubmed">23959365</ArticleId><ArticleId IdType="doi">10.1038/nrendo.2013.161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10:43&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">19092835</ArticleId><ArticleId IdType="doi">10.1038/nrg2489</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Isac E, Mart&#xed;n J-E, Assassi S, Sime&#xf3;n CP, Carreira P, Ortego-Centeno N et al (2016) Brief report: IRF4 newly identified as a common susceptibility locus for systemic sclerosis and rheumatoid arthritis in a cross-disease meta-analysis of genome-wide association studies. Arthritis Rheumatol 68:2338&#x2013;2344</Citation><ArticleIdList><ArticleId IdType="pubmed">27111665</ArticleId><ArticleId IdType="pmc">5530728</ArticleId><ArticleId IdType="doi">10.1002/art.39730</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Herrera M, Kerick M, Gonz&#xe1;lez-Serna D, Myositis Genetics Consortium, Scleroderma Genetics Consortium, Wijmenga C et al (2019) Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. Ann Rheum Dis 78:311&#x2013;319</Citation></Reference><Reference><Citation>M&#xe1;rquez A, Kerick M, Zhernakova A, Gutierrez-Achury J, Chen W-M, Onengut-Gumuscu S et al (2018) Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations. Genome Med 10:97</Citation><ArticleIdList><ArticleId IdType="pubmed">30572963</ArticleId><ArticleId IdType="pmc">6302306</ArticleId><ArticleId IdType="doi">10.1186/s13073-018-0604-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen S, Chen J, Xie X, Gao S, Zhang C et al (2020) Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj&#xf6;gren&#x2019;s syndrome highlight T cell-initiated autoimmunity. Ann Rheum Dis 79:268&#x2013;275</Citation><ArticleIdList><ArticleId IdType="pubmed">31848144</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2019-215533</ArticleId></ArticleIdList></Reference><Reference><Citation>Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarc&#xf3;n-Riquelme ME (2018) Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat Rev Rheumatol 14:75&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">29362467</ArticleId><ArticleId IdType="doi">10.1038/nrrheum.2017.220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki K (2021) Beyond GWAS: from simple associations to functional insights. Semin Immunopathol. https://doi.org/10.1007/s00281-021-00894-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-021-00894-5</ArticleId><ArticleId IdType="pubmed">34605948</ArticleId></ArticleIdList></Reference><Reference><Citation>Muskardin TLW, Niewold TB (2018) Type I interferon in rheumatic diseases. Nat Rev Rheumatol 14:214&#x2013;228</Citation><ArticleIdList><ArticleId IdType="pubmed">29559718</ArticleId><ArticleId IdType="pmc">6625751</ArticleId><ArticleId IdType="doi">10.1038/nrrheum.2018.31</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C et al (2011) Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 70:2029&#x2013;2036</Citation><ArticleIdList><ArticleId IdType="pubmed">21803750</ArticleId><ArticleId IdType="doi">10.1136/ard.2011.150326</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon KB, Briggs TA (2020) The (Orf)ull truth about IRF5 and type I interferons in SLE. Nature Rev Rheumatol 543&#x2013;544</Citation></Reference><Reference><Citation>Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K et al (2020) Inhibition of IRF5 hyperactivation protects from lupus onset and severity. J Clin Invest 130:6700&#x2013;6717</Citation><ArticleIdList><ArticleId IdType="pubmed">32897883</ArticleId><ArticleId IdType="pmc">7685739</ArticleId><ArticleId IdType="doi">10.1172/JCI120288</ArticleId></ArticleIdList></Reference><Reference><Citation>Idborg H, Zandian A, Ossipova E, Wigren E, Preger C, Mobarrez F et al (2019) Circulating levels of interferon regulatory factor-5 associates with subgroups of systemic lupus erythematosus patients. Front Immunol 10:1029</Citation><ArticleIdList><ArticleId IdType="pubmed">31156624</ArticleId><ArticleId IdType="pmc">6533644</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.01029</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N et al (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43:1186&#x2013;1188</Citation><ArticleIdList><ArticleId IdType="pubmed">22019780</ArticleId><ArticleId IdType="doi">10.1038/ng.975</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpas L, Chan RWY, Jiang P, Ni M, Sun K, Rashidfarrokhi A et al (2019) Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA. Proc Natl Acad Sci U S A 116:641&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pubmed">30593563</ArticleId><ArticleId IdType="doi">10.1073/pnas.1815031116</ArticleId></ArticleIdList></Reference><Reference><Citation>Coke LN, Wen H, Comeau M, Ghanem MH, Shih A, Metz CN et al (2021) Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-218810</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218810</ArticleId><ArticleId IdType="pubmed">33455918</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrianto I, Wang S, Wiley GB, Lessard CJ, Kelly JA, Adler AJ et al (2012) Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 64:3695&#x2013;3705</Citation><ArticleIdList><ArticleId IdType="pubmed">22833143</ArticleId><ArticleId IdType="pmc">3485412</ArticleId><ArticleId IdType="doi">10.1002/art.34642</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanda SK, Venigalla RKC, Ordureau A, Patterson-Kane JC, Powell DW, Toth R et al (2011) Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 208:1215&#x2013;1228</Citation><ArticleIdList><ArticleId IdType="pubmed">21606507</ArticleId><ArticleId IdType="pmc">3173241</ArticleId><ArticleId IdType="doi">10.1084/jem.20102177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>